These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5596746)

  • 1. [On the lipid and fatty acid composition of the blood serum in subjects with glomerulonephrits with the nephrotic syndrome].
    Pisano L; Lombardi D; Spanò G
    Boll Soc Ital Cardiol; 1967; 12(1):27-36. PubMed ID: 5596746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arterial hypertension and fatty acids of the blood in patients with chronic glomerulonephritis without the nephrotic syndrome].
    Neverov NI; Kozlova RI; Mukhin NA
    Urol Nefrol (Mosk); 1989; (1):59-63. PubMed ID: 2718286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of the fatty acids of the blood during nephrotic syndromes].
    Warembourg H; Biserte G; Bertrand M; Jaillard J; Sézille G
    J Urol Nephrol (Paris); 1967; 73(4):286-95. PubMed ID: 6057516
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the serum lipid spectrum of glomerulonephritis patients].
    Nikulina GG; Petrun' NM; Pyrig LA; Mel'man NIa
    Vrach Delo; 1985 Oct; (10):20-4. PubMed ID: 4090424
    [No Abstract]   [Full Text] [Related]  

  • 5. [alpha-Lipoprotein cholesterol content of the blood serum in nephrotic syndrome].
    Nikiforova NV; Sokolovskaia IV; Riaposova IK; Poliantseva LR
    Ter Arkh; 1982; 54(7):57-61. PubMed ID: 7135225
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in lipid metabolic indices in children with chronic kidney diseases under the influence of diet therapy].
    Korf II; Kisteneva GS; Levachev MM
    Vopr Pitan; 1980; (2):40-4. PubMed ID: 7368672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy.
    Fujita T; Nakamura N; Kumasaka R; Shimada M; Murakami R; Osawa H; Yamabe H; Okumura K
    In Vivo; 2006; 20(6B):891-3. PubMed ID: 17203785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet hypersensitivity in the nephrotic syndrome.
    Remuzzi G; Marchesi D; Mecca G; de Gaetano G; Silver M
    Proc Eur Dial Transplant Assoc; 1979; 16():487-94. PubMed ID: 548992
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fatty acid composition of total lipid and mode of distribution of fatty acid in lipid classes of blood serum in healthy subjects].
    Araki E; Nakachi N
    Rinsho Byori; 1986 Feb; 34(2):227-8. PubMed ID: 3702094
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum lipids in nephrotic syndrome.
    Banerjee SK; Sarkar AK; Chugh KS; Bansal VK; Chhuttani PN
    J Assoc Physicians India; 1972 Sep; 20(9):651-8. PubMed ID: 4654886
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipid peroxides in the plasma of patients with chronic glomerulonephritis of the nephrotic type].
    Nikiforova NV; Sokolovskaia IV; Gonchar NA
    Ter Arkh; 1983; 55(6):39-41. PubMed ID: 6612619
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fatty acid analysis by gas-liquid chromatography in the field of pediatrics. 2. Fatty acid composition in kidney diseases in children with special reference to nephrotic syndrome and its variation due to adrenocortical hormone therapy].
    Sekiya S
    Nihon Shonika Gakkai Zasshi; 1969 Nov; 73(11):1783-8. PubMed ID: 5393372
    [No Abstract]   [Full Text] [Related]  

  • 13. [Level of higher fatty acids in blood serum in diffuse glomerulonephritis in children].
    Fomina ZN; Vel'tishchev IuE
    Vopr Okhr Materin Det; 1970 Aug; 15(8):23-7. PubMed ID: 5508842
    [No Abstract]   [Full Text] [Related]  

  • 14. [Main aspects of studying lipid metabolism in clinical nephrology].
    Pyrig LA; Mel'man NIa; Petrun' NM; Nikulina GG; Anishchenko VM
    Ter Arkh; 1984; 56(7):28-31. PubMed ID: 6484829
    [No Abstract]   [Full Text] [Related]  

  • 15. [Electrophoresis of glycoproteins in urine and serum in some renal diseases].
    Bryla R
    Pol Tyg Lek; 1967 Aug; 22(32):1213-6. PubMed ID: 6056120
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of oral administration of epsilon-aminocaproic acid on serum lipids in patients with nephrotic syndrome].
    Markiewicz K; Walasek L
    Pol Tyg Lek; 1973 Jul; 28(29):1097-100. PubMed ID: 4728793
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of the epsilon-aminocaproic acid (EACA) on the protein lipoid arrangement in the nephrotic syndrome.
    Markiewicz K; Walasek L
    Pol Arch Med Wewn; 1970; 4(4):337-43. PubMed ID: 5434192
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of a therapeutic complex incorporating linetol and ascorbic and nicotinic acids for the correction of lipid metabolic disorders in children with glomerulonephritis].
    Makovetskaia GA; Rusakova NV; Lebedev AA
    Pediatriia; 1988; (10):109-10. PubMed ID: 3222077
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of serum and urinary proteins, enzymes and isoenzymes and serum lipids in nephrotic syndrome].
    Gavosto JJ; Fay OH; García CA; Arnolt RI
    Arch Fund Roux Ocefa; 1971; 5(1):73-9. PubMed ID: 5156285
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of serum lipid pattern in nephrotic syndrome in children.
    Katiyar GP; Singh CK; Agarwal KN; Singh RH
    Indian Pediatr; 1976 Feb; 13(2):83-8. PubMed ID: 1278965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.